Literature DB >> 2032421

Expression and role of integrins in adhesion of human colonic carcinoma cells to extracellular matrix components.

C Schreiner1, J Bauer, M Margolis, R L Juliano.   

Abstract

We have examined integrin expression and function in the human colon carcinoma cell line HT29, and in clonal sublines derived from the HT29 line. These cells express several different integrin subunits including beta 1, alpha 2, 3, 6 and alpha v, but do not express the classic alpha 5/beta 1 fibronectin receptor. Clonal variation in the pattern of integrin expression was quite limited. The profile of integrin expression correlates well with the adhesive behavior of HT29 cells. Thus the cells adhere well to vitronectin, laminin and type IV collagen, but not at all to fibronectin. Adhesion to collagen was completely blocked by an anti-beta 1 monoclonal antibody, indicating that beta 1 integrins mediate this process. Adhesion to laminin was strongly blocked by anti-beta 1 monoclonal or anti-beta 6 monoclonal, suggesting that the alpha 6/beta 1 complex functions in attachment to laminin; this was somewhat surprising since immunoprecipitation experiments indicate that most of the alpha 6 subunit seems to be associated with the beta 4 subunit. Despite their strong adherence to laminin, collagen and vitronectin, HT29 cells are not very motile and, in response to gradients of these proteins, do not migrate nearly as well as CHO cells tested under similar conditions. Since HT29 cells can undergo an enterocyte-like differentiation in glucose-free medium, we compared integrin expression in HT29 and its subclones during the process of differentiation. There was no correlation between the state of differentiation, as assessed by expression of brush-border hydrolases, and the level of expression of any of the integrin subunits measured. Thus the pattern of integrin expression in these colonic tumor cells seems to be a characteristic of the cell line, and is not readily modified by changes in cell growth or differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032421     DOI: 10.1007/bf01756387

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  58 in total

1.  METHOD FOR ASSAY OF INTESTINAL DISACCHARIDASES.

Authors:  A DAHLQVIST
Journal:  Anal Biochem       Date:  1964-01       Impact factor: 3.365

2.  Changes in integrin receptors on oncogenically transformed cells.

Authors:  L C Plantefaber; R O Hynes
Journal:  Cell       Date:  1989-01-27       Impact factor: 41.582

3.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

Review 4.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

Review 5.  Recent hypotheses for the origin of colon cancer.

Authors:  W R Bruce
Journal:  Cancer Res       Date:  1987-08-15       Impact factor: 12.701

6.  Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein.

Authors:  P J Brown; R L Juliano
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

Review 7.  Colon and rectal carcinoma.

Authors:  D I Soybel; D P Bliss; S A Wells
Journal:  Curr Probl Cancer       Date:  1987 Sep-Oct       Impact factor: 3.187

8.  Cell adhesion protein receptors as targets for transforming growth factor-beta action.

Authors:  R A Ignotz; J Massagué
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

9.  Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion.

Authors:  M D Pierschbacher; E Ruoslahti
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

10.  Failure of expression of class I major histocompatibility antigens to alter tumor immunogenicity of a spontaneous murine carcinoma.

Authors:  D A Carlow; R S Kerbel; B E Elliott
Journal:  J Natl Cancer Inst       Date:  1989-05-10       Impact factor: 13.506

View more
  14 in total

1.  RhoA-dependent switch between alpha2beta1 and alpha3beta1 integrins is induced by laminin-5 during early stage of HT-29 cell differentiation.

Authors:  S P Gout; M R Jacquier-Sarlin; L Rouard-Talbot; P Rousselle; M R Block
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow.

Authors:  J Haier; M Y Nasralla; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

3.  Biosynthesis, surface expression and function of the fibronectin receptor after rat liver cell transformation to tumorigenicity.

Authors:  M Decastel; M A Doyennette-Moyne; E Gouet; M Aubery; P Codogno
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

4.  Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin.

Authors:  J A Varner; D A Emerson; R L Juliano
Journal:  Mol Biol Cell       Date:  1995-06       Impact factor: 4.138

Review 5.  Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix.

Authors:  K V Honn; D G Tang
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Comparative evaluation of integrin alpha- and beta-chain expression in colorectal carcinoma cell lines and in their tumours of origin.

Authors:  K Koretz; S Brüderlein; C Henne; T Fietz; M Laqué; P Möller
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Src activity alters alpha3 integrin expression in colon tumor cells.

Authors:  Christina Leah B Kline; Thomas L Olson; Rosalyn B Irby
Journal:  Clin Exp Metastasis       Date:  2008-10-07       Impact factor: 5.150

8.  Phospholipids reduce the intraperitoneal adhesion of colonic tumor cells in rats and adhesion on extracellular matrix in vitro.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Jens Otto; Britta Schmitz; Stefan Mueller; Claudia Weiss; Lothar Tietze; Volker Schumpelick
Journal:  Int J Colorectal Dis       Date:  2004-08-12       Impact factor: 2.571

Review 9.  O-Mannosylation and human disease.

Authors:  Christina M Dobson; Samuel J Hempel; Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Cell Mol Life Sci       Date:  2012-11-01       Impact factor: 9.261

10.  Reduction of peritoneal carcinomatosis by intraperitoneal administration of phospholipids in rats.

Authors:  Jens Otto; Petra Lynen Jansen; Stefan Lucas; Volker Schumpelick; Marc Jansen
Journal:  BMC Cancer       Date:  2007-06-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.